IM Cannabis Corp. (IMCC)
NASDAQ: IMCC · IEX Real-Time Price · USD
0.590
+0.023 (4.08%)
Apr 26, 2024, 10:29 AM EDT - Market open
Company Description
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany.
It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands.
The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel.
IM Cannabis Corp.
| Country | Israel |
| Founded | 1980 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 95 |
| CEO | Oren Shuster |
Contact Details
Address: 1 Adelaide Street East, Unit 801 Toronto, A6 M5C 2V9 Ontario, Canada | |
| Phone | 416-256-4202 |
| Website | imcannabis.com |
Stock Details
| Ticker Symbol | IMCC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001792030 |
| CUSIP Number | 44969Q208 |
| ISIN Number | CA44969Q3070 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Marc Lustig M.B.A., M.Sc. | Executive Chairman |
| Oren Shuster | Chief Executive Officer and Director |
| Uri Birenberg | Chief Financial Officer |
| Richard Balla | Chief Executive Officer of Adjupharm |
| Advocate Michal Lebovitz Nissimov | General Counsel |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 16, 2024 | 6-K | Report of foreign issuer |
| Apr 9, 2024 | 6-K | Report of foreign issuer |
| Apr 4, 2024 | 6-K | Report of foreign issuer |
| Apr 4, 2024 | 6-K | Report of foreign issuer |
| Apr 1, 2024 | 6-K | Report of foreign issuer |
| Mar 28, 2024 | 20-F | Annual and transition report of foreign private issuers |
| Mar 25, 2024 | 6-K | Report of foreign issuer |
| Mar 20, 2024 | 6-K | Report of foreign issuer |
| Mar 6, 2024 | 6-K | Report of foreign issuer |
| Feb 28, 2024 | 6-K | Report of foreign issuer |